TOLERABILITY AND ADVERSE EVENTS The most common adverse events associated with GLP-1 receptor agonist use in general are gastrointestinal in nature, with mild-to-moderate diarrhea, nausea, and vomiting being the most commonly reported events
However, the data reveals a nuanced story regarding how patients actually handle these drugs over time
The company clearly sees potential in monthly dosing, with Novos Chief Scientific Officer Marcus Schindler, Ph.D., telling investors in March that infrequent dosing, in particular in diabetes, but also obesity, are big topics for us. Brian Vandahl, SVP of global research technologies at the Big Pharma, echoed this sentiment in his comments accompanying this mornings press release
When you consume food, your intestines release hormones that signal fullness to your brain and regulate blood sugar levels